12:00 AM
Nov 10, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Plavix clopidogrel: Phase III ongoing

The partners published the design of the ongoing double-blind, international Phase III CURRENT- OASIS 7 trial of Plavix. The study is comparing a standard vs. high-dose regimen of the drug in a planned 18,000-20,000 patients who present with ACS symptoms and are scheduled to...

Read the full 201 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >